| Type I diabetes mellitus |
-1.89 |
7.81e-4 |
38/43 (88.37%) |
HLA-B;HLA-C;HLA-F;...
|
| Kaposi sarcoma-associated herpesvirus infection |
-1.91 |
4.31e-4 |
172/193 (89.12%) |
MAPK3;RAF1;MAPKAPK2;...
|
| T cell receptor signaling pathway |
-1.91 |
4.46e-4 |
93/104 (89.42%) |
MAPK3;RAF1;MAP3K8;...
|
| Intestinal immune network for IgA production |
-1.93 |
4.63e-4 |
38/48 (79.17%) |
HLA-DMB;CXCR4;CD80;...
|
| Pertussis |
-1.93 |
4.81e-4 |
64/76 (84.21%) |
ITGB1;MAPK3;CALML4;...
|
| Systemic lupus erythematosus |
-1.94 |
5.00e-4 |
45/135 (33.33%) |
C2;C1QB;HLA-DQB1;...
|
| Inflammatory bowel disease |
-1.97 |
5.21e-4 |
58/65 (89.23%) |
RORC;RORA;IL18RAP;...
|
| PD-L1 expression and PD-1 checkpoint pathway in cancer |
-1.99 |
0.00e+0 |
79/89 (88.76%) |
JAK2;TLR2;CSNK2A2;...
|
| Primary immunodeficiency |
-2.00 |
0.00e+0 |
33/38 (86.84%) |
RFXANK;TAP1;ZAP70;...
|
| NOD-like receptor signaling pathway |
-2.02 |
0.00e+0 |
145/181 (80.11%) |
TYK2;CASP8;TRAF3;...
|
| Neutrophil extracellular trap formation |
-2.03 |
0.00e+0 |
101/189 (53.44%) |
SELP;SIGLEC9;MAPK3;...
|
| Lipid and atherosclerosis |
-2.08 |
0.00e+0 |
190/215 (88.37%) |
PLCG1;IL18;CD14;...
|
| Autoimmune thyroid disease |
-2.09 |
0.00e+0 |
46/53 (86.79%) |
HLA-B;HLA-C;HLA-F;...
|
| Asthma |
-2.09 |
0.00e+0 |
25/31 (80.65%) |
RNASE3;HLA-DQB1;HLA-DPB1;...
|
| Allograft rejection |
-2.10 |
0.00e+0 |
32/38 (84.21%) |
HLA-B;HLA-C;HLA-F;...
|
| Coronavirus disease |
-2.10 |
0.00e+0 |
215/232 (92.67%) |
RPL3L;IFNA6;RPL18;...
|
| Staphylococcus aureus infection |
-2.10 |
0.00e+0 |
72/95 (75.79%) |
CFB;FCGR2C;KRT32;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-2.11 |
0.00e+0 |
62/70 (88.57%) |
PLCG1;PAK1;ATP6V1E1;...
|
| Amoebiasis |
-2.13 |
0.00e+0 |
99/102 (97.06%) |
CD1E;ARG2;CD1B;...
|
| Legionellosis |
-2.13 |
0.00e+0 |
51/57 (89.47%) |
IL18;CD14;IL1B;...
|
| TNF signaling pathway |
-2.14 |
0.00e+0 |
103/112 (91.96%) |
SELE;IL1B;FOS;...
|
| Antigen processing and presentation |
-2.15 |
0.00e+0 |
60/78 (76.92%) |
KIR2DL4;HSPA6;PSME1;...
|
| Chemokine signaling pathway |
-2.16 |
0.00e+0 |
163/192 (84.9%) |
ADCY7;NFKBIA;CCL22;...
|
| Hematopoietic cell lineage |
-2.29 |
0.00e+0 |
90/99 (90.91%) |
CD1B;IL6;ITGA2B;...
|
| Th1 and Th2 cell differentiation |
-2.32 |
0.00e+0 |
80/92 (86.96%) |
JAK2;IL2RA;ZAP70;...
|
| NF-kappa B signaling pathway |
-2.35 |
0.00e+0 |
90/104 (86.54%) |
BCL2A1;CSNK2A2;ZAP70;...
|
| Graft-versus-host disease |
-2.38 |
0.00e+0 |
32/42 (76.19%) |
HLA-B;HLA-C;HLA-F;...
|
| IL-17 signaling pathway |
-2.50 |
0.00e+0 |
84/94 (89.36%) |
IL1B;S100A7;FOS;...
|
| Viral protein interaction with cytokine and cytokine re... |
-2.55 |
0.00e+0 |
84/100 (84%) |
CCL24;CXCL6;CXCR3;...
|
| Rheumatoid arthritis |
-2.68 |
0.00e+0 |
78/93 (83.87%) |
HLA-DQB1;ATP6V1E1;IL18;...
|
